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Conclusions: The point dose measurements results for the 
small fields improve when the distance of the jaws from the 
MLC field is also increased. Therefore we presently are using 
a minimal fixed jaw position of 4x4 in our clinic for field sizes 
less than 2x2. We are also considering in using a grid of 1.25 
mm for small lesions (≤2 cm of diameter) instead of the 1 mm 
grid in order to gain plan calculation time while maintaining 
accuracy. Due to the presented differences in point doses 
measurements for the smallest fields sizes (≤2 cm), we are 
currently limiting the monitor units of our IMRT plans to avoid 
small segments (<0.5cm). 
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Purpose/Objective: While dosimetry of small fields is quite 
well understood for photons this is not the case for electrons. 
Moreover, here no recommendation exists which detector can 
be used reliably in small field electron dosimetry. In this 
work different detectors were compared for their properties 
at small electron fields. The aim was to find the most 
suitable detector for small field electron dosimetry.  
Materials and Methods: All measurements were carried out 
at an Elekta SL15 linear accelerator (Elekta, Crawley UK) 
using electron energies of 4, 10 and 15 MeV and field sizes 
from 1x1 cm² to 20x20 cm². The detectors investigated in 
this work were Roos (Type 34001) chamber, Advanced Markus 
(Type 34045) chamber and the E-Diode (Type 60017) (PTW-
Freiburg, Freiburg, Germany). Depth dose curves, profiles 
and output factors were recorded in water using a MP3 Water 
phantom (PTW-Freiburg, Freiburg, Germany) at a source to 
surface distance of 100 cm. Dose profiles and output factors 
were measured at zref.  
Results: The output factors (figure 1a) show deviations of the 
Roos chamber with respect to the E-Diode ranging from -2% 
(4x4 cm²) to -50% (1x1 cm²). Also the depth dose curves of 
the Roos chamber do not match those of the diode or 
Advanced Markus chamber for small fields. For field sizes 
from 10x10 cm² down to 1x1 cm² Advanced Markus chamber 
and E-Diode are in good agreement for depth dose curves and 
output factors (mean deviation: 1.2%). For large electron 
fields the diode shows an overestimation of the output factor 
with respect to the two other detectors of about 5% for field 
sizes larger than 10x10 cm². 
For dose profiles (figure 1b) Advanced Markus chamber and E-
Diode show good agreement of the penumbra width, while 
the Roos chamber shows a much larger penumbra due to the 




Conclusions: While the Roos chamber shows excellent results 
for field sizes of 5x5 cm² and larger, it clearly is not suitable 
for smaller fields or the measurement of dose profiles, as it 
shows deviations of up to 50% with respect to the other two 
detectors. For small fields, as well as for dose profiles, the E-
Diode is the best choice, but it shows an overestimation of 
the output factors for field sizes of 20x20 cm² and therefore 
should not be used for large fields. The Advanced Markus 
chamber is a good choice for measuring dose profiles, output 
factors and depth dose curves over the whole field size range 
from 1x1 cm² to 20x20 cm². The local difference over the 
whole range compared to Roos chamber for large fields or E-
Diode for small fields is better than 5% for all measurement 
situations investigated. 
In this study, we showed that for small electron fields the 
Advanced Markus chamber and the E-Diode can be used 
equally within 5% local difference. 
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Purpose/Objective: TG176 shows that skin dose has become 
a concern for modern radiotherapy techniques and devices. 
Within this framework, the objective of this work is the 
comparison of results from different detectors when they are 
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used for dose measurements in the build-up zone for 
megavoltage photon beams. The study focused in ultrathin 
thermoluminescent (TL) detectors with an effective point of 
measurement (EPOM) smaller than 5 mg/cm2, Gafchromic 
films (EPOM~120 mg/cm2 ) and a novel plastic scintillator 
detector (EPOM ~0.8 g/cm2). 
Materials and Methods: Two types of ultrathin LiF:Mg,Cu,P-
based TL dosimeters (MCP-Ns from TLD Poland and TLD-2000F 
from Conqueror Electronics Technology Co. Ltd.), EBT2 
Gafchromic films (Ashland) and an Exradin W1 plastic 
scintillator (Standard Imaging) have been tested against the 
results of a PTW-Freiburg 23392 extrapolation chamber (EC), 
entrance window ~0.7 mg/cm2. The experimental 
measurements were also compared with Monte Carlo dose 
calculations with the PENELOPE/penEasy code. 
All the studied detectors were used to measure the dose at 
build-up region and in particular the surface dose on a plastic 
waterTM phantom for 6 and 15 MV photon beams from a Varian 
Clinac 2100 C/D, 10 x 10 cm2 field-size and SSD=100 cm. The 
percentage depth-dose distributions were measured with 
EBT2 films and Exradin W1 scintillator detector. The phantom 
consisted of 30× 30 cm2 slabs with thicknesses ranging from 
0.1 to 5 cm. In all cases, for each depth at least three 
measurements were taken and the experimental set-up was 
repeated in three different days. Regarding the EC 
measurements, a special support made of wood was 
constructed and successive depths were measured by adding 
the corresponding plastic water slabs over the entrance 
window of the chamber while fixing the SSD to 100 cm. For 
three electrode separations, three measurements were made 
at the positive and negative voltage bias and the 
corresponding average was calculated. 
Results: Monte Carlo simulation results were in good 
agreement with the EC measurements (average differences < 
2 %). Among the tested detectors, ultrathin TLD’s showed the 
best accuracy for surface dose estimations (within statistical 
uncertainties, 3% 1 SD). The correction factors for surface 
dose determination with the other detector types ranged 
from 0.3 to 0.8. Regarding dose measurements in the build-
up zone, Gafchromic films results were in good agreement 
with the EC measurements (average differences <2 %) with 
the exception of the surface dose. As expected due to its 
effective point of measurement, the Exradin W1 
overestimated the surface dose and its results were in 
agreement with the EC measurements (within 5%) for depths 
beyond 5 mm. 
Conclusions: Although extrapolation chambers are the most 
suited detectors for build-up measurements for megavoltage 
photon beams their use is not practical. Among the tested 
detectors, ultrathin TLD’s and Gafchromic films showed a 
good accuracy for dose measurements in the build-up zone. 
In particular, ultrathin TL detectors are the detector of 
choice for surface dose measurements. 
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Purpose/Objective: The goal of real-time 3D in vivo 
dosimetry, which we are currently capable of, is to prevent 
serious injuries to patients during radiotherapy by 
automatically halting the linac in case of uncorrectable dose 
deviations. These are, however, not well-defined. This study 
is exploring a new way of dose verification, called hot-spot 
analysis (HSA), which has been directly derived from a 
possible definition of an uncorrectable dose deviation. The 
parameters and alert criteria for HSA are of paramount 
importance: false positives would be detrimental to 
treatment throughput and may cause anxiety. False 
negatives, on the other hand, would defeat the purpose of 
real-time verification. By retrospectively analysing a large 
number of in vivo dosimetry measurements using HSA, we 
aim to determine its usefulness for clinical implementation of 
real-time 3D dosimetry at various alert levels. Note that real-
time dosimetry is not intended to find smaller, correctable 
deviations. 
Materials and Methods: An uncorrectable dose deviation is 
defined as a local overdose which would induce unacceptable 
toxicity to the patient. Note that it is not assumed that the 
patient’s setup is correct; hence, any such local overdose is 
regarded as an uncorrectable dose deviation regardless its 
actual position. In accordance with this definition, HSA seeks 
hot spots in the delivered dose distribution, defining a hot 
spot to be a volume with a certain minimum diameter and a 
minimum local overdose (MLO) within a region of interest 
(ROI) – the volume enclosed by a predefined isodose level in 
the delivered dose.  
In this study, a minimum diameter of a hot spot of 17 mm, 
corresponding to a volume of 5cc, was used and two ROIs 
were evaluated: defined by the 1 and 2 Gy isodose surfaces. 
To obtain insight in the distribution of deviations, the 
threshold MLO is varied from 2 – 100%, allowing in the most 
extreme case a single-fraction overdosage of 4 Gy. HSA was 
then used to re-analyse reconstructed 3D dose distributions 
of 1095 randomly selected incident-free treatments given in 
2013, all of which had been verified (offline) using our 3D 
EPID-based in vivo dosimetry method. For each treatment 
and each set of HSA parameters, the presence of hot spots 
was determined. 
Results: Table 1 shows for both ROIs the number of 
treatments having at least one hot spot as a function of 
threshold MLO; the distribution of positive alerts is clearly 
not normal. Individual inspection of these alerts is ongoing, 
but seems to indicate that either they are not big enough to 
be considered as an incident alert, e.g. for the low MLO 
values, or are caused by limitations of our 3D dose 
reconstruction model. 
 
